The government of Sudan's Red Sea State urged the international community and humanitarian organisations to support its efforts to provide basic needs for thousands of displaced people in the region.

- CBL-514 received both FDA Orphan Drug Designation and Fast Track designation for Dercum's disease treatment earlier this year. - CBL-514 Phase 2 study for Dercum's disease showed that it could ...

today announced the submission of the updated regulatory file for LUMEVOQ ® gene therapy to the French medicines safety agency Agence Nationale de Sécurité du Médicament et des Produits de Santé (ANSM ...